PUBCHEM ID | 8048 |
Molecular Weight (g/mol) | 200.318 |
Molecular Formula | C12H24O2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 10 |
IUPAC Name | ethyl decanoate |
Canonical SMILES | CCCCCCCCCC(=O)OCC |
PUBCHEM IUPAC INCHIKEY | RGXWDWUGBIJHDO-UHFFFAOYSA-N |
Solubility Level | 3 |
Vapour Pressure | -1.964 |
XLOGP3 AA | 4.6 |
CACTVS TPSA | 26.3 |
BBB Level | 0 |
Absorption Level | 0 |
EXT PPB#Prediction | 1 |
AlogP98 | 4.23 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Non-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Non-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 11.9514 g/kg_body_weight |
Ocular Irritancy | None |
Hepatotoxic#Prediction | 0 |
Effected Human Genes |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | Moderate |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | 110-38-3 | TP53 | Homo sapiens | qHTS assay for small molecule agonists of the p53 signaling pathway: Summary | Inactive | |
2 | 110-38-3 | NR3C1 | Homo sapiens | qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway | Inactive | |
3 | 110-38-3 | AR | Homo sapiens | qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway | Inactive | |
4 | 110-38-3 | Thrb | Homo sapiens | qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway | ||
5 | 110-38-3 | ESR1 | Homo sapiens | qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | 110-38-3 | Ethyl decanoate |